- $727.37m
- $1.50bn
- $976.67m
- 61
- 41
- 18
- 34
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 780 | 886 | 1,059 | 1,100 | 977 |
Cost of Revenue | |||||
Gross Profit | 144 | 232 | 393 | 309 | 330 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 859 | 887 | 1,154 | 1,343 | 1,101 |
Operating Profit | -79.2 | -1.13 | -95.8 | -244 | -124 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -80.8 | -18.5 | -97.3 | -250 | -125 |
Provision for Income Taxes | |||||
Net Income After Taxes | -80.8 | -18.5 | -91.2 | -250 | -126 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -80.8 | -18.5 | -110 | -321 | -130 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -80.8 | -23 | -117 | -323 | -131 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.882 | -0.134 | -0.892 | -2.46 | -1.61 |